Discover
CLOV
Clover Health Investments, Corp.
4.58
2 x 3.24
6 x 5.01
bid
ask
+
0.02
0.44%
4 @ 07:09 PM
5.07 +0.49 (10.68%)
| Ytd | 94.89% | |
| 1y | 64.75% |
4.44
day range
4.60
1.58
52 week range
5.59
| Open | 4.50 | Prev Close | 4.56 | Low | 4.44 | High | 4.60 | Mkt Cap | 2.43B |
| Vol | 5.18M | Avg Vol | 4.27M | EPS | -0.05 | P/E | N/A | Forward P/E | 30.53 |
| Beta | 2.46 | Short Ratio | 5.87 | Inst. Own | 33.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.41 | 200-d Avg | 3.36 | 1yr Est | 5.38 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-11-03 | 2026-09 | -0.01 | N/A | N/A | N/A |
| 2026-08-05 | 2026-06 | 0.04 | 0.05 | 0.01 | 29.40% |
| 2026-05-06 | 2026-03 | 0.07 | 0.07 | N/A | N/A |
| 2026-02-26 | 2025-12 | -0.1 | -0.05 | 0.05 | 51.04% |
| 2025-11-04 | 2025-09 | 0.02 | -0.05 | -0.07 | -350.00% |
| 2025-08-05 | 2025-06 | -0.01 | -0.02 | -0.01 | -116.68% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-08-06 | UBS | Upgrade | Neutral | Neutral |
| 2026-07-21 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-06-11 | UBS | Upgrade | Neutral | Neutral |
| 2026-06-04 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-05 | Leerink Partners | Upgrade | Market Perform | Market Perform |
Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-01-05 | CLINTON CHELSEA | Director | 602.81K | Stock Award(Grant) |
| 2026-01-06 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.86M | Conversion of Exercise of derivative security |
| 2026-01-05 | KOUZOUKAS DEMETRIOS L | Director | 605.98K | Stock Award(Grant) |
| 2025-05-18 | KUIPERS PETER J | Chief Financial Officer | 6.35M | Stock Award(Grant) |
| 2026-05-12 | PRIEST BRADY PATRICK | Officer | 2.04M | Sale |
| 2026-10-06 | REYNOSO JAMIE L. | Officer | 2.79M | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-06-29 | Blackrock Inc. | 35.11M | 160.79M | 8.06% |
| 2026-06-29 | Vanguard Capital Management LLC | 18.04M | 82.61M | 4.14% |
| 2026-06-29 | Geode Capital Management, LLC | 10.85M | 49.67M | 2.49% |
| 2026-06-29 | State Street Corporation | 10.18M | 46.63M | 2.34% |
| 2026-06-29 | Nuveen, LLC | 6.29M | 28.82M | 1.44% |
| 2026-06-29 | Charles Schwab Investment Management, Inc. | 5.52M | 25.29M | 1.27% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-06-29 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 12.98M | 59.44M | 2.98% |
| 2026-08-30 | iShares Trust-iShares Russell 2000 ETF | 10.96M | 50.18M | 2.52% |
| 2026-06-29 | VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 4.65M | 21.28M | 1.07% |
| 2026-07-30 | Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 4.60M | 21.07M | 1.06% |
| 2026-08-30 | iShares Trust-iShares Russell 2000 Growth ETF | 3.99M | 18.28M | 0.92% |
| 2026-05-30 | VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 2.10M | 9.62M | 0.48% |
Dividend
| Dividend | Date |
|---|---|
| 0.1 | 2021-08-23 |